Why the study?
Are platelet nitric oxide pathways altered in women with gestational hypertension and preeclampsia compared to healthy pregnant controls?
Are platelet nitric oxide pathways altered in women with gestational hypertension and preeclampsia compared to healthy pregnant controls?
Gestational hypertension and preeclampsia are associated with marked changes in platelet nitric oxide pathways, with higher NO metabolites and iNOS activation in gestational hypertension compared to preeclampsia.
Should not yet change management of gestational hypertension or preeclampsia; leaves open mechanistic and prognostic roles of platelet NO pathways.
The aim of the study was to investigate platelet nitric oxide (NO) pathways in women with Gestational Hypertension (GH), Preeclampsia (PE) and Controls. Platelet NO(x) and peroxynitrite (ONOO(-)) levels, inducible (iNOS) and endothelial nitric oxide synthase (eNOS) and Nitrotyrosine expression (N-Tyr) in 30 women with GH, 30 with PE and 30 healthy pregnant controls, age, parity and gestational age-matched, were assessed. Platelet NO(x) and ONOO(-) levels were significantly higher in GH and PE vs. Controls, with higher levels in GH vs. PE. At the same way, iNOS and N-Tyr were significantly higher in GH and PE vs. Controls, with higher levels in GH vs. PE. Since GH expressed higher amount of NO metabolites and higher activation of iNOS compared to PE, we can hypothesize that the severity of hypertensive pathology is almost not related to only NO metabolism, this research confirmed that GH and PE are associated with marked changes in NO pathways; it is not easy to understand if they could be interpreted as causes or consequence of these pathologic states.
No takes yet. Share an insight, caveat, or question.
Mazzanti et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: